[The efficacy and safety of daratumumab in relapsed and refractory multiple myeloma].
Jia YJ, Liu H, Wang LR, Wang T, Feng R, Chen YJ, Wang M, Guo HX, Wen L, Duan WB, Yang YZ, Wang FR, Chen YY, Huang XJ, Lu J.
Jia YJ, et al. Among authors: chen yy, chen yj.
Zhonghua Nei Ke Za Zhi. 2020 May 1;59(5):347-352. doi: 10.3760/cma.j.cn112138-20191217-00821.
Zhonghua Nei Ke Za Zhi. 2020.
PMID: 32370462
Chinese.